UBE2W expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.67643676718399E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.84590137514351E-11 |
Normal-vs-Stage2 |
5.564500E-04 |
Normal-vs-Stage3 |
2.03769999762571E-08 |
Normal-vs-Stage4 |
1.76769709980817E-12 |
Stage1-vs-Stage2 |
2.814600E-01 |
Stage1-vs-Stage3 |
5.726000E-01 |
Stage1-vs-Stage4 |
2.302200E-02 |
Stage2-vs-Stage3 |
2.302000E-01 |
Stage2-vs-Stage4 |
3.092100E-02 |
Stage3-vs-Stage4 |
3.612400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.0327960708878E-11 |
Normal-vs-AfricanAmerican |
1.6251444634463E-12 |
Normal-vs-Asian |
8.315500E-02 |
Caucasian-vs-AfricanAmerican |
1.218030E-04 |
Caucasian-vs-Asian |
4.457800E-01 |
AfricanAmerican-vs-Asian |
8.908500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.58595400437889E-12 |
Normal-vs-Female |
3.25361959596648E-12 |
Male-vs-Female |
4.523200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.10680045526135E-10 |
Normal-vs-Age(41-60Yrs) |
1.62470037423645E-11 |
Normal-vs-Age(61-80Yrs) |
5.87280224451092E-11 |
Normal-vs-Age(81-100Yrs) |
5.83149999999755E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.387600E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.934030E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.957200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.679000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.956800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.791200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.375640E-04 |
Normal-vs-Grade 2 |
6.5301000051754E-08 |
Normal-vs-Grade 3 |
1.98152605435098E-12 |
Normal-vs-Grade 4 |
1.63324909152607E-12 |
Grade 1-vs-Grade 2 |
8.346600E-01 |
Grade 1-vs-Grade 3 |
2.837800E-01 |
Grade 1-vs-Grade 4 |
5.663500E-02 |
Grade 2-vs-Grade 3 |
1.959530E-02 |
Grade 2-vs-Grade 4 |
6.752200E-04 |
Grade 3-vs-Grade 4 |
6.509800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.00829999905017E-08 |
Normal-vs-ccB subtype |
7.57530005390805E-09 |
ccA subtype-vs-ccB subtype |
3.067600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.1864000044356E-09 |
Normal-vs-N1 |
4.967600E-04 |
N0-vs-N1 |
7.286800E-01 |
|
|